India’s Dolutegravir market softened in January as buyer resistance around tender timing and normalized logistics trimmed upward pressure. Container availability returned to normal after the lull, reducing freight surcharges, while Chinese suppliers kept offers for key fluorinated intermediates flat. Mid-January buying was subdued as donors waited between tenders and manufacturers drew on contracted volumes; by late January, exporters offered marginal discounts. The net tone was bearish, driven by comfortable inventories at formulation units and limited urgency among bulk institutional buyers ahead of a Global Fund tender in February. Demand patterns were mixed across end-users, leaving prices lower on the month. Institutional and donor procurement remained weak as bulk purchasers awaited the Global Fund antiretroviral tender, while export-oriented ARV formulation manufacturers pulled contracted January volumes rather than adding spot lots. Private hospital procurement stayed steady, and domestic public-sector call-offs were limited after NACO fulfilled its annual requirement. Looking ahead, the continued decline is expected, with gradual stabilization as tender cycles and logistics normalize.
Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility.
Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
